Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis : A Scienti

Key Words

  • ACC/AHA Scientific Statements
  • athletes
  • arrhythmogenic right ventricular cardiomyopathy
  • cardiomyopathy
  • cardiovascular abnormalities
  • cardiovascular magnetic resonance
  • hypertrophic cardiomyopathy
  • myocarditis
  • sudden death

Hypertrophic cardiomyopathy (HCM) 1 and 2 is a major focus of this document given that it is the single most common cause of sudden death in young competitive athletes in the United States, responsible for at least one-third of these events (3).

 


Autor / Fonte:Barry J Maron, James E Udelson, Robert O Bonow, Rick A Nishimura, Michael J Ackerman, N A Mark Estes, Leslie T Cooper, Mark S Link, Martin S Maron Journal of the American College of Cardiology 2015 October 27
Link: http://www.sciencedirect.com/science/article/pii/S0735109715065717/pdfft?md5=6509379f512e8ef001fb8b2c7c01d813&pid=1-s2.0-S0735109715065717-main.pdf